UK vaccines network: mapping priority pathogens of epidemic potential and vaccine pipeline developments

Noad, R. J. et al. (2019) UK vaccines network: mapping priority pathogens of epidemic potential and vaccine pipeline developments. Vaccine, 37(43), pp. 6241-6247. (doi: 10.1016/j.vaccine.2019.09.009) (PMID:31522809) (PMCID:PMC7127063)

[img]
Preview
Text
196797.pdf - Published Version
Available under License Creative Commons Attribution.

574kB

Abstract

During the 2013–2016 Ebola outbreak in West Africa an expert panel was established on the instructions of the UK Prime Minister to identify priority pathogens for outbreak diseases that had the potential to cause future epidemics. A total of 13 priority pathogens were identified, which led to the prioritisation of spending in emerging diseases vaccine research and development from the UK. This meeting report summarises the process used to develop the UK pathogen priority list, compares it to lists generated by other organisations (World Health Organisation, National Institutes of Allergy and Infectious Diseases) and summarises clinical progress towards the development of vaccines against priority diseases. There is clear technical progress towards the development of vaccines. However, the availability of these vaccines will be dependent on sustained funding for clinical trials and the preparation of clinically acceptable manufactured material during inter-epidemic periods.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Hosie, Professor Margaret
Authors: Noad, R. J., Simpson, K., Fooks, A. R., Hewson, R., Gilbert, S. C., Stevens, M. P., Hosie, M. J., Prior, J., Kinsey, A. M., Entrican, G., Simpson, A., Whitty, C. J.M., and Carroll, M. W.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Vaccine
Publisher:Elsevier
ISSN:0264-410X
ISSN (Online):1873-2518
Published Online:12 September 2019
Copyright Holders:Copyright © 2019 Crown Copyright
First Published:First published in Vaccine 37(43): 6241-6247
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record